Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Management of Concomitant Abdominal Aortic Aneurysm and Intra-abdominal, Retroperitoneal Malignancy

V. Treska, J. Molacek, B. Certik, K. Houdek, P. Hosek, V. Soukupova, C. Stogerova, A. Svejdova

. 2021 ; 35 (1) : 517-523. [pub] -

Language English Country Greece

Document type Journal Article

BACKGROUND/AIM: As the population ages, there are increasing findings of coincidental diseases such as abdominal aortic aneurysm (AAA) and intra-abdominal, retroperitoneal malignancy. The aim of this study was to propose an optimal treatment procedure for these patients. PATIENTS AND METHODS: Over a twenty-year-period, surgery was performed on a total of 1,098 patients with AAA and 32 (2.9%) patients with AAA and intra-abdominal, retroperitoneal malignancy: 18 renal, 6 colorectal carcinomas, 3 carcinomas of the small intestine, 3 primary liver tumours, 1 stomach carcinoma and 1 teratoma. The median age of patients was 72.5 years, there were 20 men (62.5%) and 12 women (37.5%). A one-stage procedure was performed on 19 patients (59.4%), and a two-stage procedure on 13 (40.6%) patients. RESULTS: The average time of hospitalization was 12.4±6.9 days (median=11.0 days) for one-stage procedure, for a two-stage procedure 21.3±9.3 days (median=20.0 days), p=0.0045. Seven patients (21.9%) died within 30 days after the operation. All the deaths were in the group of one-stage procedures (p=0.0252). The 1-, 3- and 5-year overall survival for patients following one-stage and twostage procedures was 61.0/56.3/51.5% and 89.0/79.9/53.0% respectively (p=0.1199). CONCLUSION: Symptomatic disease must be resolved first. Two-stage procedures are the method of choice and offer better short-term results compared to one-stage procedures.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019542
003      
CZ-PrNML
005      
20230222093451.0
007      
ta
008      
210728s2021 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/invivo.12286 $2 doi
035    __
$a (PubMed)33402504
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Treska, Vladislav $u Department of Surgery, School of Medicine in Pilsen, Charles University in Prague, Prague, Prague, Czech Republic; treska@fnplzen.cz
245    10
$a Management of Concomitant Abdominal Aortic Aneurysm and Intra-abdominal, Retroperitoneal Malignancy / $c V. Treska, J. Molacek, B. Certik, K. Houdek, P. Hosek, V. Soukupova, C. Stogerova, A. Svejdova
520    9_
$a BACKGROUND/AIM: As the population ages, there are increasing findings of coincidental diseases such as abdominal aortic aneurysm (AAA) and intra-abdominal, retroperitoneal malignancy. The aim of this study was to propose an optimal treatment procedure for these patients. PATIENTS AND METHODS: Over a twenty-year-period, surgery was performed on a total of 1,098 patients with AAA and 32 (2.9%) patients with AAA and intra-abdominal, retroperitoneal malignancy: 18 renal, 6 colorectal carcinomas, 3 carcinomas of the small intestine, 3 primary liver tumours, 1 stomach carcinoma and 1 teratoma. The median age of patients was 72.5 years, there were 20 men (62.5%) and 12 women (37.5%). A one-stage procedure was performed on 19 patients (59.4%), and a two-stage procedure on 13 (40.6%) patients. RESULTS: The average time of hospitalization was 12.4±6.9 days (median=11.0 days) for one-stage procedure, for a two-stage procedure 21.3±9.3 days (median=20.0 days), p=0.0045. Seven patients (21.9%) died within 30 days after the operation. All the deaths were in the group of one-stage procedures (p=0.0252). The 1-, 3- and 5-year overall survival for patients following one-stage and twostage procedures was 61.0/56.3/51.5% and 89.0/79.9/53.0% respectively (p=0.1199). CONCLUSION: Symptomatic disease must be resolved first. Two-stage procedures are the method of choice and offer better short-term results compared to one-stage procedures.
650    _2
$a senioři $7 D000368
650    12
$a aneurysma břišní aorty $x komplikace $x epidemiologie $x chirurgie $7 D017544
650    12
$a karcinom z renálních buněk $7 D002292
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a nádory ledvin $7 D007680
650    _2
$a mužské pohlaví $7 D008297
650    12
$a retroperitoneální nádory $x chirurgie $7 D012186
650    12
$a nádory žaludku $7 D013274
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Molacek, Jiri $u Department of Surgery, School of Medicine in Pilsen, Charles University in Prague, Prague, Prague, Czech Republic
700    1_
$a Certik, Bohuslav $u Department of Surgery, School of Medicine in Pilsen, Charles University in Prague, Prague, Prague, Czech Republic
700    1_
$a Houdek, Karel $u Department of Surgery, School of Medicine in Pilsen, Charles University in Prague, Prague, Prague, Czech Republic
700    1_
$a Hosek, Petr $u Biomedicine Center, School of Medicine, Pilsen, Czech Republic
700    1_
$a Soukupová, Veronika $u Department of Surgery, School of Medicine in Pilsen, Charles University in Prague, Prague, Prague, Czech Republic $7 xx0282376
700    1_
$a Stogerova, Christiana $u Department of Surgery, School of Medicine in Pilsen, Charles University in Prague, Prague, Prague, Czech Republic
700    1_
$a Svejdova, Aneta $u Department of Surgery, School of Medicine in Pilsen, Charles University in Prague, Prague, Prague, Czech Republic
773    0_
$w MED00175831 $t In Vivo $x 1791-7549 $g Roč. 35, č. 1 (2021), s. 517-523
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33402504 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20230222093446 $b ABA008
999    __
$a ok $b bmc $g 1690384 $s 1139988
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 35 $c 1 $d 517-523 $e - $i 1791-7549 $m In Vivo $n In Vivo $x MED00175831
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...